CANC
Tema Oncology ETF
📎 Investment Objective
The CANC - Tema Oncology ETF seeks to provide investment exposure to companies involved in the research, development, and commercialization of cancer treatment therapies.
Overview
ETF tracking Tema Oncology ETF
Performance
Price Chart
Investment Summary
📎 Investment Objective
The CANC - Tema Oncology ETF seeks to provide investment exposure to companies involved in the research, development, and commercialization of cancer treatment therapies.
🎯 Investment Strategy
The ETF tracks an index that selects and weights companies based on their involvement in the oncology industry, including pharmaceutical, biotechnology, and medical device firms focused on cancer-related products and services.
✨ Key Features
- Provides diversified exposure to the oncology and cancer treatment industry
- Invests in a range of companies across the cancer therapy value chain
- Passively managed to track the underlying index
- Low expense ratio of 0.00%
⚠️ Primary Risks
- Sector-specific risk, as the fund is concentrated in the oncology industry
- Potential volatility due to the speculative and high-growth nature of many cancer treatment companies
- Lack of performance history, as the fund is newly launched
- Liquidity risk due to the small asset size and trading volume
👤 Best For
The CANC ETF may be suitable for investors seeking long-term exposure to the oncology industry and the potential growth opportunities in cancer treatment technologies. However, due to the fund's limited track record and small asset size, it may be more appropriate for investors with a higher risk tolerance and a long-term investment horizon.